The Netherlandsraboinvestments.com/team/ventures
Rabo Ventures is the venture capital team of Rabo Investments, the captive investment arm of Rabobank, a leading Dutch cooperative bank specializing in food and agriculture. It invests in early-stage companies focused on innovation, sustainability, and the energy transition within the global Food & Agriculture sector, spanning the entire value chain from farm to fork.
The firm provides initial equity investments typically between EUR 1 million and EUR 4 million, with potential for follow-on funding, targeting Seed to Series B rounds. It takes minority stakes, often through preferred equity or convertible debt, in companies demonstrating strong product-market fit and scalable models. Operations are centered in Europe, with a strong emphasis on the Netherlands, while supporting portfolio companies through Rabobank's extensive global network and industry relationships.
As a strategic investor backed by Rabobank, Rabo Ventures leverages deep sector expertise and connections to major F&A players to help portfolio companies scale. This positions it as a key player in fostering sustainable innovations in food systems and related technologies. The team includes professionals with backgrounds in life sciences, finance, and sustainability, led by figures such as Pieter van der Meché as Head of Rabo Ventures.
Rabo Ventures forms part of Rabo Investments' broader mandate, which encompasses private equity, fund investments, and corporate venturing, all aligned with Rabobank's mission of 'Growing a Better World Together.' It has a portfolio of around 20 companies and actively participates in rounds like the Series A extension for BIOWEG, a German biotech firm developing biodegradable ingredients.
Also known as Rabo Corporate Investments.
chemXplore tracks 1 project involving Rabo Ventures, of which one is active.
Rabo Ventures's role on them: Investor / Financier.
1 new construction.
Expected to start operating, per year.
Targeting: Cellulose (1)
Construction starts Q4 2026; plant capacity 10,000 t/y with first commercial volumes in 2028; Series A extended and EU grant bring total funding to €35m.
By country, the most active first.